Summary
EMU, with the help of partners will analyse 3 potential scenarios in regards to working with the pharmaceutical industry. For each method, UTARTU will assess feasibility in terms of infrastructure requirements, potential yields, timeframes for development and initial demand.
• Transgenic farm animals as bioreactors to synthesize biopharmaceutical products such as peptides and hormones: This is the scenario that EMU has made the most progress towards,
• Transgenic animals as test subjects for drug development where phenotypic and epigenetic information can be monitored.
• Inheritable genetic modification to produce animals as bioreactors or test subjects
More information & hyperlinks